Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a, interleukin (IL) IL-6 and IL-10, vascular cell adh...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Format:	article
Language:	RU
Published:	IP Morozov P.V. 2020
Subjects:	russian study victory ii arterial hypertension organ protection pulse wave velocity central arterial pressure central aortic pressure nephroprotection markers of endothelial damage ¬fixed combinations valsartan amlodipine hydrochlorothiazide vamloset® co-vamloset Diseases of the circulatory (Cardiovascular) system RC666-701
Online Access:	https://doaj.org/article/749491d786994f6493162a7284467d61
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Similar Items